title: Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade.
authors.affiliation: 1 Keio University School of Medicine Tokyo, Japan.
authors.forename: Sarasa
authors.initials: S
authors.lastname: Isobe
authors.affiliation: 1 Keio University School of Medicine Tokyo, Japan.
authors.forename: Masaharu
authors.initials: M
authors.lastname: Kataoka
authors.affiliation: 2 Kyorin University School of Medicine Tokyo, Japan and.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Aimi
authors.affiliation: 3 Kyorin University School of Health Sciences Tokyo, Japan.
authors.forename: Shinobu
authors.initials: S
authors.lastname: Gamou
authors.affiliation: 2 Kyorin University School of Medicine Tokyo, Japan and.
authors.forename: Toru
authors.initials: T
authors.lastname: Satoh
authors.affiliation: 1 Keio University School of Medicine Tokyo, Japan.
authors.forename: Keiichi
authors.initials: K
authors.lastname: Fukuda
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D052006:Bone Morphogenetic Protein Receptors, Type II / Q000235:genetics*; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D011464:Epoprostenol; C498218:BMPR2 protein, human; D052006:Bone Morphogenetic Protein Receptors, Type II